This free survey is powered by QUESTIONPRO.COM
  1. Surveys
  2. 2011
  3. May
  4. P
  5. Psych
0%
Exit Survey »
 
 
Have you received a Saphris (asenapine) sales call in the past 30 days?
 
Yes
 
No
 
 
How does the frequency of a rep visits compare to other products in the atypical market?
Much Lower Somewhat Lower Same Somewhat Higher Much Higher
Saphris
Fanupt
Latuda
 
 
 
As part of the sales call, did you receive product samples of Saphris?
 
Yes
 
No
 
 
Were the sample quantities received adequate relative to other atypicals?
not at all adequate Slightly below adequate adequate Slightly better than adequate More than adequate
Saphris
Fanupt
Latuda
 
 
 
This question is regarding use of new drugs. Which of the following 3 best describes what you do.
 
(1) Do you typically adopt products upon FDA approval
 
(2) wait until other colleagues begin to adopt
 
(3) wait until the product is a mainstay standard treatment?
 
 
 
Do you have any other comments on what makes you use newly launched products?
   
 
Survey Software Powered by QuestionPro Survey Software